| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Vanderbilt University Medical Center [N. T. W., W. M. M., S. A. H.], and the Veterans Administration Medical Center [S. A. H.], Nashville, Tennessee 37232, and Ludwig Institute for Cancer Research, Bern Branch, Inselspital, University of Bern, 3010 Bern, Switzerland [N. T. W.]
In vitro and in vivo investigations have shown that nontoxic treatment with vitamin A (retinol) has an inhibitory effect on the growth of malignant cells. The tumorigenic CaMa-15 cell line responds to both retinol and retinoic acid under both anchorage-dependent and anchorage-independent conditions, reducing growth or colony formation by at least 50%. To date, there have been few studies on the effects of vitamin A on xenotransplanted neoplastic cells. Twenty-five adult female nude rats (rnu/rnu) were inoculated in the inguinal fat pad with 106 CaMa-15 cells, a tumorigenic epithelial cell line. The rats were divided into three groups: ten high dose (3 mg retinol/day i.p.); five low dose (30 µg retinol/day i.p.); and ten controls (corn oil i.p.). All animals were housed in specific-pathogen-free conditions and permitted access to sterile laboratory chow (5.4 µg retinol/g chow) and water ad libitum. Rats were sacrificed at 21 days after inoculation. Onset of tumor development occurred between Days 9 and 13 in all groups. Tumors grew progressively and were reduced in mean diameter by 26% (p = <0.05) with high-dose retinol and 44% (p = <0.02) by low-dose treatment. No clinical signs of vitamin A toxicity were apparent. Necropsy and radiological examination revealed no evidence of toxic effects or metastases. These results indicate that vitamin A can reduce the growth of xenotransplanted tumorigenic cells at nontoxic levels in T-cell-deficient hosts. The nude rat offers a potential model to study the inhibitory effects of retinoids on xenotransplanted cancers.
1 Supported in part by National Cancer Institute Research Grant RRO-5424-21. This work was presented in part at the 67th Annual Meeting of the Federation of American Societies for Experimental Biology, 1983 (43).
2 To whom requests for reprints should be addressed.
Received 10/11/83. Accepted 3/ 6/84.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |